You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adenocarcinoma

Showing 51 - 75 of 8,125
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Appendiceal Adenocarcinoma, Colorectal Trial in Houston (Circulating tumoral DNA directed neoadjuvant therapy arm)

Not yet recruiting
  • Appendiceal Adenocarcinoma
  • Colorectal
  • Circulating tumoral DNA directed neoadjuvant therapy arm
  • Houston, Texas
    M D Anderson Cancer Center
Jul 7, 2023

Metastatic Pancreatic Adenocarcinoma Trial in Ann Arbor (Devimistat, Modified FOLFIRINOX)

Not yet recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Ann Arbor, Michigan
    Rogel Cancer Center
Jun 26, 2023

Gastric Adenocarcinoma Trial in Pessac (Gastrectomy)

Recruiting
  • Gastric Adenocarcinoma
  • Gastrectomy
  • Pessac, France
    Hôpital du Haut Lévêque
Mar 23, 2023

Gastric / Gastroesophageal Junction Adenocarcinoma Trial in Shanghai (envafolimab and lenvatinib combined with

Enrolling by invitation
  • Gastric / Gastroesophageal Junction Adenocarcinoma
  • envafolimab and lenvatinib combined with paclitaxel-albumin
  • Shanghai, Shanghai, China
    Fudan University Cancer Hospital
Sep 3, 2023

Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)

Recruiting
  • Adenocarcinoma
  • +8 more
  • Radiotherapy targeted to the primary lesion
  • +7 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 7, 2023

Adenocarcinoma, Pancreatic Ductal Trial in New York (Autogene cevumeran, Atezolizumab, mFOLFIRINOX)

Recruiting
  • Adenocarcinoma, Pancreatic Ductal
  • Autogene cevumeran
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 21, 2023

Pancreatic Ductal Adenocarcinoma Trial in New York (Stereotactic body radiotherapy (SBRT), Zimberelimab, Quemliclustat)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Stereotactic body radiotherapy (SBRT)
  • +4 more
  • New York, New York
    Columbia University Irving Medical Center
Sep 15, 2023

Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Proficient Mismatch Repair Trial in China (S1,

Not yet recruiting
  • Adenocarcinoma of the Stomach
  • +2 more
  • Hangzhou, Zhejiang, China
  • +4 more
May 23, 2023

Gastric or Gastroesophageal Junction Adenocarcinoma Trial in Nanjing (neoadjuvant chemo-hypofractionated radiotherapy plus PD-1

Active, not recruiting
  • Gastric or Gastroesophageal Junction Adenocarcinoma
  • neoadjuvant chemo-hypofractionated radiotherapy plus PD-1 antibody (Tislelizumab)
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital
Jul 4, 2023

HER2-positive Advanced Gastric Cancer, HER2-positive Gastroesophageal Junction Adenocarcinoma Trial (Trastuzumab deruxtecan)

Not yet recruiting
  • HER2-positive Advanced Gastric Cancer
  • HER2-positive Gastroesophageal Junction Adenocarcinoma
  • Trastuzumab deruxtecan
  • (no location specified)
Aug 11, 2023

Barrett's Esophagus and Esophageal Adenocarcinoma, Searching for

Recruiting
  • Esophageal Neoplasms
    • Ghent, Oost-Vlaanderen, Belgium
      University hospital Ghent
    Jan 13, 2023

    Klotho _ LRP-6 _ Gastric Adenocarcinoma

    Not yet recruiting
    • Gastric Adenocarcinoma
    • +2 more
    • Prognostic study
    • (no location specified)
    Jan 29, 2023

    Rectal Adenocarcinoma Trial in Tampa (Capecitabine, Radiation Therapy, FOLFOX regimen)

    Recruiting
    • Rectal Adenocarcinoma
    • Tampa, Florida
      Moffitt Cancer Center
    Jan 24, 2023

    Gastric Cancer Trial (S-1, Oxaliplatin, Cadonilimab)

    Not yet recruiting
    • Gastric Cancer
    • S-1, Oxaliplatin, Cadonilimab
    • (no location specified)
    Jul 10, 2023

    Gastroesophageal Adenocarcinoma Trial (toripalimab FOLFOX)

    Not yet recruiting
    • Gastroesophageal Adenocarcinoma
    • toripalimab FOLFOX
    • (no location specified)
    Aug 3, 2023

    Metastatic Pancreatic Ductal Adenocarcinoma Trial in Washington (BXCL701, Pembrolizumab)

    Not yet recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Washington, District of Columbia
      Georgetown Lombardi Comprehensive Cancer Center
    Jan 23, 2023

    Predict Lymphovascular Invasion in Pancreatic Ductal

    Recruiting
    • Predictive Cancer Model
    • Pancreas Cancer
      • Tianjin, Tianjin, China
        Tianjin Medical University Cancer Institute and Hospital
      Aug 10, 2023

      Lung Adenocarcinoma, Stage IV NSCLC, PD-1 Inhibitor Trial (Serplulimab and Bevacizumab injection)

      Not yet recruiting
      • Lung Adenocarcinoma
      • +3 more
      • Serplulimab and Bevacizumab injection
      • (no location specified)
      Dec 21, 2022

      Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Rochester (Bio-specimen Collection: Blood, Bio-specimen

      Recruiting
      • Pancreatic Cancer
      • +3 more
      • Bio-specimen Collection: Blood
      • +2 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Nov 21, 2023

      Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Trial (XELOX combined with Fruquintinib and Sintilimab)

      Not yet recruiting
      • Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
      • XELOX combined with Fruquintinib and Sintilimab
      • (no location specified)
      Oct 17, 2023

      Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial

      Not yet recruiting
      • Advanced Esophageal Adenocarcinoma
      • +14 more
      • (no location specified)
      Jan 3, 2023

      Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Chuo Ku (TRK-950, Ramucirumab,

      Not yet recruiting
      • Gastric Adenocarcinoma
      • +2 more
      • TRK-950
      • +2 more
      • Chuo Ku, Japan
        Osaka International Cancer Institute
      Sep 14, 2023

      Oesophageal Adenocarcinoma, Gastric Adenocarcinoma Trial in France (Capmatinib, Spartalizumab)

      Suspended
      • Oesophageal Adenocarcinoma
      • Gastric Adenocarcinoma
      • Besançon, France
      • +6 more
      Feb 1, 2023

      Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer, Locally Advanced Unresectable Gastric

      Available
      • Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer
      • +3 more
      • Morristown, New Jersey
        AMG Hematology/Oncology
      Sep 15, 2023

      HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma Trial (SHR-A1811, Ramucirumab / Paclitaxel/

      Not yet recruiting
      • HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
      • SHR-A1811
      • Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan
      • (no location specified)
      Nov 6, 2023